1-4 of 4
clinical pathways
Close
Sort by
Journal Articles

Implementation of an Evidence-Based Care Pathway for Emergency Department Management of Sickle Cell Vaso-Occlusive Crisis Leads to Improved Clinical Outcomes

Jennifer Yui, MD, Scott A. Peslak, MD PhD, David Lambert, MD, Eric Russell, MD, Farzana Sayani, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4678.
https://doi.org/10.1182/blood-2019-123868
Published: 2019
Journal Articles

A Clinical Pathway Reduces Admissions for Vaso-Occlusive Pain in Sickle Cell Disease

Wallace Jones, MD, Leann Myers, Aditi Dasgupta, Jessica Debord
Journal: Blood
Blood (2019) 134 (Supplement_1): 3383.
https://doi.org/10.1182/blood-2019-127097
Published: 2019
Journal Articles

Using Natural Language Processing to Determine Chemotherapeutic Regimens Administered within 30 Days Prior to Death in Acute Myelogenous Leukemia Patients

Hanahlyn M Park, BSN, MN(c), Vicky Sandhu, MD MPH, Paul Fearn, MBA, PhDc), Kathleen Shannon Dorcy, RN, MN, PhD, Elihu H. Estey, MD, Emily Silgard, MS
Journal: Blood
Blood (2014) 124 (21): 1267.
https://doi.org/10.1182/blood.V124.21.1267.1267
Published: 2014
Journal Articles

Improvement In Acute Management of Vaso-Occlusive Pain In Pediatric Sickle Cell Disease with Use of a Clinical Pathway

Katherine Ender, M.D., M.S., Jennifer Freed, M.D., John Babineau, M.D., Mary Tresgallo, DNP, MPH, William Schechter, M.D., John Saroyan, M.D., Anupam Kharbanda, M.D., M.S.
Journal: Blood
Blood (2010) 116 (21): 2660.
https://doi.org/10.1182/blood.V116.21.2660.2660
Published: 2010